Nilotinib Plus Pegylated Interferon-α2b in CML

Clinical trial NCT01866553 · TERMINATED

Trial details

NCT number: NCT01866553
Sponsor: Amsterdam UMC, location VUmc
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Myeloid Leukemia

Start date: 2013-04-01
Primary completion: 2016-04-08
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.